Concepedia

T Pulido‐Rios

TP

3

Publications

249

Citations

3

H-Index

1999

Active since

Affiliations

Theravance Biopharma (United States)(Current)

T Pulido‐Rios is an author at Theravance Biopharma (United States) specializing in molecular physiology, signal transduction, and drug discovery.

Top concepts

Publications per year

1999–2007

3

Publications

3

The 5‐HT<sub>4</sub> receptor agonist, tegaserod, is a potent 5‐HT<sub>2B</sub> receptor antagonist <i>in vitro</i> and <i>in vivo</i>

David T. Beattie, Jacqueline A.M. Smith, Daniel G. Marquess et al. · British Journal of Pharmacology · 2004 · 119 citations · Full text

RS‐127445: a selective, high affinity, orally bioavailable 5‐HT<sub>2B</sub> receptor antagonist

Douglas W. Bonhaus, Lee A. Flippin, Robert Greenhouse et al. · British Journal of Pharmacology · 1999 · 117 citations · Full text

, , +17

A comparison of the pharmacological properties of guinea‐pig and human recombinant 5‐HT<sub>4</sub>receptors

R. Vickery, Ngoc Mai, Elad Kaufman et al. · British Journal of Pharmacology · 2007 · 13 citations · Full text

Rows per page

1–3 of 3